United States · FDA National Drug Code directory
TheraBreath Anticavity
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 10237-265_3e626c65-3a8b-ec3c-e063-6394a90ad8f4
- Product NDC
- 10237-265
- Form
- RINSE
- Composition / generic term
- Sodium Fluoride
- Labeler
- Church & Dwight Co., Inc.
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20240815
- Source listing expiry
- 20261231
Source-listed ingredients
- SODIUM FLUORIDE — .002 mg/10mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1000 mL in 1 BOTTLE, PLASTIC (10237-265-01) · 10237-265-01
- 2 BOTTLE in 1 PACKAGE (10237-265-21) / 1000 mL in 1 BOTTLE · 10237-265-21
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →